Skip to main content

John Newman

Stock Analyst at Canaccord Genuity

Total Price Targets
5
Stocks Covered
3
Sectors
Healthcare
Most Recent
Nov 3, 2025

Notable Calls (Last 12 Months)

Most Bullish

  • ACLX+44.0%
    Arcellx, Inc.
    $130.00 targetNov 3, 2025

Most Bearish

  • ACLX+44.0%
    Arcellx, Inc.
    $130.00 targetNov 3, 2025

Stocks Covered by John Newman

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
ACLXArcellx, Inc.$130.00$115.07+13.0%2Nov 3, 2025
REGNRegeneron Pharmaceuticals, Inc.$850.00$703.72+20.8%2Apr 22, 2025
ALLOAllogene Therapeutics, Inc.$55.00$2.15+2464.1%1Dec 3, 2021

Recent Activity

  • Nov 3, 2025— Set$130.00price target onACLX(Arcellx, Inc.)
  • Apr 22, 2025— Set$850.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
  • Jul 20, 2022— Set$32.00price target onACLX(Arcellx, Inc.)
  • Dec 3, 2021— Set$55.00price target onALLO(Allogene Therapeutics, Inc.)
  • May 21, 2021— Set$700.00price target onREGN(Regeneron Pharmaceuticals, Inc.)

Frequently Asked Questions

Who is John Newman?

John Newman is a stock analyst at Canaccord Genuity covering 3 stocks primarily in Healthcare. They have issued 5 price targets since May 21, 2021.

What stocks does John Newman cover?

John Newman currently covers 3 stocks, including ACLX, REGN, ALLO.

What is John Newman's latest price target?

John Newman's most recent price target was $130.00 on ACLX (Arcellx, Inc.), set on Nov 3, 2025.

What is John Newman's highest price target?

John Newman's highest issued price target is $850.00 on REGN, set on Apr 22, 2025.

Coverage based on publicly published price targets. Not investment advice.